Exploring the neuroprotective role of GLP-1 agonists against Alzheimer's disease: Real-world evidence from a propensity-matched cohort
<h3 dir="ltr">Background</h3><p dir="ltr">Alzheimer's disease (AD) is a leading cause of dementia with societal and economic burdens. While recent therapies offer disease-modifying potential, concerns remain about efficacy and safety. Glucagon-like peptide-...
Saved in:
| Main Author: | Majd A AbuAlrob (23073877) (author) |
|---|---|
| Other Authors: | Adham Itbaisha (22392508) (author), Yahya Kayed Abujwaid (23073880) (author), Ayah Abulehia (23073883) (author), Abdallah Hussein (21696423) (author), Boulenouar Mesraoua (16936932) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide.
by: Sara, Sokary
Published: (2025) -
The promise of tirzepatide: A narrative review of metabolic benefits
by: Sara Sokary (17337724)
Published: (2025) -
Exploring beyond numeric weight loss: The metabolic effects of semaglutide
by: Sara Sokary (17337724)
Published: (2025) -
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
by: Abdelilah Arredouani (10914455)
Published: (2025) -
An overview of diabetes mellitus in pregnant women with obesity
by: Mohammed, Bashir
Published: (2024)